Introduction {#sec1}
============

High-throughput mass spectrometry (MS)-based analyses generate large and complex data sets measuring hundreds to thousands of biomolecules (e.g., peptides, metabolites, and lipids). The term quality control (QC) can hold different meanings depending on the field. Here, QC refers to reducing process-based sources of variation and extreme biological outliers. The goal of this is to reduce bias in downstream statistical results and biological inference. QC processing of the MS-quantified biomolecule peak intensities is essential for removing outliers and other random effects arising from the mapping of raw mass spectra to identified biomolecules with observed values. Only after QC processing, including normalization, should statistical analysis be performed. Given the missing data issues inherent to liquid chromatography (LC)--MS-based proteomics data^[@ref1],[@ref2]^ and the poor or inconsistent results of imputation to fill in missing data,^[@ref1],[@ref3],[@ref4]^ QC and statistical methods that are robust to missing data are needed.

At the time of this writing, on Bioconductor^[@ref5]^ there are a large number of R^[@ref6]^ packages for processing MS data under the Proteomics, Metabolomics, and Lipidomics categories. The most comprehensive QC processing packages for proteomics in R focus on the raw data,^[@ref7]−[@ref10]^ which although necessary and valuable are not sufficient for removing process-based errors that will bias downstream statistical analysis. Several R packages are available for statistical analysis of proteomics data^[@ref11],[@ref12]^ and have excellent functionality for statistics but minimal QC.^[@ref12],[@ref13]^ Other packages support individualized analyses of single samples or biomolecules but rely on the user to add the functionality to statistically evaluate the data^[@ref14]^ or have limited functionality for filtering biomolecules and performing statistical analysis.^[@ref15]^ Additional packages^[@ref16]−[@ref22]^ cover extensive capabilities for QC and normalization, but none are focused on robust QC and statistics of mass spectrometry peak intensity data or specifically designed to be robust to the complex missing data of global proteomics. These missing data arise from a combination of left-censoring, instrument error, and physicochemical properties of the peptides, making imputation difficult.^[@ref2],[@ref4]^ This is the overall gap that *pmartR* fills through end-to-end data processing capabilities.

The *pmartR* R package provides QC, data pre-processing, and statistical analysis functionality that is both robust to missing values in analyses and uses the missing data structure to identify qualitative biomarker candidates. This is the primary capability that distinguishes *pmartR* from other mass spectrometry R packages, which rely on imputation of data. Many of the *pmartR* functions use attributes to capture information about the data set and the analyses that have been performed, allowing the user to query the data object and obtain a record of the analysis steps. *pmartR* has the added benefit of being applicable to multiple MS-quantified omics data types, including proteomics, metabolomics, and lipidomics gas chromatography (GC-) or LC-MS data. Finally, *pmartR* provides visualization and summary methods that allow the user to understand the effect of their filtering, normalization, and other analysis choices as they move through the QC, EDA, and statistics pipeline.

Software Design and Functionalities {#sec2}
===================================

The *pmartR* software package is implemented in R; the open source package is available for download at <http://github.com/pmartR/pmartR>. *pmartR* provides capabilities for preparing MS data for, and for performing, statistical analysis using simple function calls. Data objects are automatically updated with information about the analysis as it is performed, streamlining the data exploration, QC, and statistical analysis process for the user. Below, we provide brief descriptions of the capabilities of *pmartR*, and more details can be found on the github page and in the R package vignettes.

Data Format and Pre-Processing {#sec2.1}
------------------------------

Functions in the *pmartR* package operate primarily on an S3 data object defined at the beginning of an analysis by the user. There are separate S3 classes for peptide data (either unlabeled or labeled with an isobaric tag), protein data, metabolite data, and lipid data ([Table [1](#tbl1){ref-type="other"}](#tbl1){ref-type="other"}), and the data object is created using the R function corresponding to the object type \[as.pepData(), as.isobaricpepData(), as.proData(), as.metabData(), or as.lipidData()\]. In R, S3 data objects have predefined structures and properties. Methods specific to a given data type can then be written by the developer and called generically by a user. For example, calling summary() on a vector of numbers returns the minimum, maximum, etc., of the vector's values, while calling summary() on a pepData object returns quantities such as the number of samples, the number of biomolecules, and the amount of missing data.

###### Types of Data Supported by *pmartR* and Their Corresponding S3 Object Classes[a](#tbl1-fn1){ref-type="table-fn"}

  type of data          S3 object class
  --------------------- --------------------------
  peptide (unlabeled)   pepData
  peptide (labeled)     isobaricpepData, pepData
  protein               proData
  metabolite            metabData
  lipid                 lipidData

Note that an isobaricpepData object is also a pepData object, but the converse is not true.

The starting point for analysis using *pmartR* is the quantified peak intensities of identified biomolecules. More specifically, there are two required data tables and one optional data table for the creation of the *pmartR* S3 data object. Each component corresponds to a data.frame in R, which can be imported using the base functionality of R. (1) e_data is required and contains the expression data. This is a *p* × (*n* + 1) data.frame, where *p* is the number of biomolecules and *n* is the number of samples. Each row corresponds to a biomolecule, and each column corresponds to a sample except for one column, which gives a unique biomolecule identifier. (2) f_data is required and contains feature data about the samples. This is a data.frame with *n* rows, one for each sample, and one column for sample names with additional columns for information about the samples (e.g., treatment group or other experimental information). (3) e_meta is optional and contains metadata about the biomolecules. This is a data.frame with one column for the biomolecule identifier and the remaining columns for additional biomolecule information (e.g., for peptide data, e_meta might include a peptide-to-protein mapping). [Supporting Information file S1](http://pubs.acs.org/doi/suppl/10.1021/acs.jproteome.8b00760/suppl_file/pr8b00760_si_001.xlsx) contains the e_data, f_data, and e_meta data tables corresponding to the data set discussed in [Experimental Methods](#sec3){ref-type="other"}. Plot and summary methods for these data objects provide a visualization of the samples in the data set (as boxplots) and a quick overview of the data set properties (number of samples, number of biomolecules, and amount of missing data), respectively.

Several publications have shown that more reliable statistical results are obtained using methods that are robust to missing data to analyze mass spectrometry data.^[@ref1]^ Thus, *pmartR* allows a user to analyze their data without imputation of missing values. However, there are some instances where it may be appropriate or desirable to impute missing values. Numerous R packages exist to perform imputation; therefore, *pmartR* does not attempt to recreate any of this functionality. A user should impute their data before using *pmartR*, if desired, and take care in choosing an imputation method as several studies have compared, contrasted, and demonstrated the differences in data generated by different imputation methodologies for mass spectrometry data.^[@ref1],[@ref4]^

Functions for data value replacement \[e.g., replace 0s with NA's to represent missing values; edata_replace()\] and transformation \[e.g., to a log scale; edata_transform()\] are provided to prepare data for statistical analyses. Statistical analysis with *pmartR* allows the user to make comparisons between two or more groups; we therefore provide a function for associating group membership with each sample, and this information is saved as part of the data object and used by some of the downstream filtering methods and functions\[group_designation()\].

For compatibility with the widely used *MSnbase* package,^[@ref7]^ which contains an array of functionality for processing raw proteomics data, the *pmartR* package includes a function to transform data objects back and forth between the MsnSet class from *MSnbase* and the pepData class from *pmartR*. This allows users to take advantage of the raw data processing from *MSnbase* as well as the robust QC and statistical processing from *pmartR* without having to manually configure the data objects.

Data QC: Data Summary and Filtering {#sec2.2}
-----------------------------------

QC is crucial for accurate and unbiased downstream statistical analyses; therefore, *pmartR* offers a number of different functions to aid in this process, including multiple filter types and visualizations. Summary and plot methods are available for the data set S3 objects, to describe basic characteristics of the data and creating a boxplot for each sample; for the filter S3 objects, to summarize the effects of applying the filter and aid the selection of a threshold for the filter; for the normalization S3 object, to see boxplots before and after normalization; and for the summary S3 objects, to display information about the summary and graph the output. See [Supporting Information file S2](http://pubs.acs.org/doi/suppl/10.1021/acs.jproteome.8b00760/suppl_file/pr8b00760_si_002.pdf) for example code.

### Data Summary and Visualizations {#sec2.2.1}

*pmartR* provides functions for generating numeric summaries (in the form of data.frames), graphical summaries to learn about the presence and patterns of missing values, a correlation heatmap, and probabilistic principal component analysis (PPCA).^[@ref23]^ The correlation matrix is computed using Pearson correlation on pairwise complete observations in base R,^[@ref24]^ via cor_result(), which creates an object of class corRes. This object can be displayed in a heatmap using the plot() command. PPCA is a PCA algorithm that can be used in the presence of missing data. The principal components are calculated using projection pursuit estimation, which implements an expectation--maximization algorithm when data are missing. We implement PPCA from the *pcaMethods* package in R^[@ref23]^ using a wrapper function for dimension reduction, dim_reduction(), which creates an object of class dimRes. This object can be used to create a PCA scores plot via the plot() command.

### Filters {#sec2.2.2}

*pmartR* allows the user to filter both biomolecules and samples based on objective or subjective characteristics of the data. Biomolecules can be filtered according to the number of observed values \[molecule_filter()\] or the variability according to the coefficient of variation \[cv_filter()\] across samples. They can also be filtered in anticipation of specific statistical tests that will be run subsequently \[imdanova_filter()\] via the removal of biomolecules for which no statistical test can be performed.^[@ref25]^ A robust Mahalanobis distance (rMd) filter is used to identify potential outlying samples where each sample is assigned a p-value as described previously.^[@ref26]^ The rMD filter \[rmd_filter()\] is based on any user-defined subset of the following five metrics: correlation, proportion of missing values, median absolute deviation, skew, and kurtosis. The rmd_filter() function uses a default p-value threshold of 0.0001; however, we recommend using the additional visualization capability for this method in combination with expert knowledge prior to removing outlying samples. User-specified biomolecules (e.g., contaminants and biomolecules of particular interest) or samples can be either removed from or retained in the data set using the custom_filter(). Each filter has an associated summary and plot method (except for the custom_filter(), which does not have a plot method) that can assist in making decisions about filtering thresholds and provide additional insight into the data set.

Normalization {#sec2.3}
-------------

A variety of data normalization options are available in *pmartR*. For labeled data, normalization to a reference sample is supported \[normalize_isobaric()\]. This can be followed by any of the other normalization approaches available in *pmartR*, which include quantile normalization \[normalize_quantile()\] and loess normalization^[@ref27],[@ref28]^ \[normalize_loess()\] that operate on a biomolecule by biomolecule basis and a host of global normalization types \[normalize_global()\] that operate on a sample by sample basis.

For global normalization, one may choose a normalization strategy from the available options, or for proteomics data, the statistical procedure for the analyses of peptide abundance normalization strategies^[@ref29]^ (SPANS) can be used to aid in the selection of a normalization strategy. The global normalization strategies consist of two parts, a subset function and a normalization function. The subset specifies the biomolecules (presented below in the context of peptide-level data) with which to generate the normalization factors using the normalization function. The normalization factors are then applied to the full data set. Currently available subset functions include the following. (1) All: Use all peptides to compute normalization factor(s). (2) Percentage of peptides present (PPP): Subset the data to peptides present in at least *p* percent of samples. (3) Rank invariant peptides (RIP): First, subset peptides to those present in every sample (e.g., complete peptides). Next, subject each peptide to a Kruskal--Wallis test on group, and those peptides not significant at a given p-value threshold are retained as invariant. (4) PPP-RIP: Rank invariant peptides among peptides present in a given percentage of samples. (5) Top "l" order statistics (LOS): The peptides with intensities in the top "l" order statistics are retained.

The currently available normalization functions (presented below in the context of log~2~-transformed peptide-level data) include the following, where missing values are ignored when computing means, medians, or standard deviations and data are on a log scale. (1) Median centering: The sample-wise median (median of all peptides in a given sample) is subtracted from each peptide in the corresponding sample. (2) Mean centering: The sample-wise mean (mean of all peptides in a given sample) is subtracted from each peptide in the corresponding sample. (3) *Z*-score transformation: The sample-wise mean (mean of all peptides in a given sample) is subtracted from each peptide, and the result is divided by the sample-wise standard deviation (standard deviation of all peptides in a given sample) in the corresponding sample. (4) Median absolute deviation (MAD) transformation: The sample-wise median (median of all peptides in a given sample) is subtracted from each peptide, and the result is divided by the sample-wise MAD (e.g., the MAD of all peptides in a given sample) in the corresponding sample.

Protein Quantification {#sec2.4}
----------------------

For proteomics data, a number of algorithms for protein rollup are available in *pmartR* via the protein_quant() function, some of which account for different isoforms of the proteins. For any type of rollup, the user must specify a method for estimating protein abundances from observed peptides ("rollup", "Rrollup", "Qrollup", or "Zrollup")^[@ref30]^ and a function to use for combining the peptide-level data (either "mean" or "median"). More information about the rollup methods can be found in the *pmartR* vignette. To account for protein isoforms, Bayesian Proteoform Quantification^[@ref31]^ (BP-Quant) can be used.

Statistics {#sec2.5}
----------

The *pmartR* package includes functions to analyze omics data for both quantitative and qualitative differences in abundance data between two or more groups \[imd_anova()\] using the IMD-ANOVA method.^[@ref25]^ This functionality can handle up to two grouping factors (or "main effects") with or without additional covariate information. Differences between the groups of main effects can be tested, adjusting for the covariates. The data can be paired or not.

A quantitative test for differential abundance in the data is accomplished via an analysis of variance (ANOVA) for each biomolecule. The *Rcpp* package is used to accelerate computation,^[@ref33]^ and different ANOVA implementations are applied depending on the complexity of the supplied data. For example, if only two groups are supplied, then ANOVA reduces to a two-sample t-test that assumes equal variance for the two groups. Alternatively, if two groups are present and a covariate correction is required, then the effect of the covariates is removed using a reduced maximum likelihood approach. After the covariate correction is applied, a two-factor ANOVA is used to detect the difference between all combinations of groups or between main effects as appropriate.

In the event that there are not enough data to test for a quantitative difference in abundance between groups, one can still test for a qualitative difference in groups using the independence of missing data (IMD) test.^[@ref25]^ This is often the case for proteomics data where a number of peptides or proteins could have missing data for one of several reasons. The idea is to assess if there are more missing values than expected by random chance in one group compared to another. If there are an adequate number of nonmissing data available, then the χ^2^ test of independence can be used.^[@ref34]^ This assumption often fails, however, so a modified version of the χ^2^ test, called the g-test,^[@ref25]^ should be used. The availability of both quantitative and qualitative statistical models and tests is one of the features that distinguish this package from other frequently used packages in R for mass spectrometry data.

Reporting and Results {#sec2.6}
---------------------

The objects returned by imd_anova() are of the class statRes. Special functions are available for objects of this class, including print(), summary(), and plot(). The summary() function prints the type of test that was run, any adjustments that were made, the p-value threshold used to define significance, and a table that summarizes the number of significant biomolecules (up or down relative to the reference group) for each comparison.

The plot() function can be used to produce any of the following four plots. 1) A bar plot shows the number of significant biomolecules grouped by comparisons and indicates the direction of change. 2) A volcano plot is a plot of the ANOVA p-value by the fold-change estimate for each biomolecule, differentiated by test and faceted by comparison; 3) for the g-test, the resulting plot represents each biomolecule by the number of observations in each group as (*x*, *y*) coordinates. 4) A heatmap illustrates the fold changes for the statistically significant biomolecules (available only if comparisons among more than two groups are made).

Experimental Methods {#sec3}
====================

We use a subset of samples from a larger study examining the effect of inhalation endotoxin exposure and obesity on lung inflammation in mice.^[@ref35]^ The full experimental design and description of proteomics data generation have been presented previously.^[@ref35]^ This identified and quantified example data set is available as [Supporting Information file S1](http://pubs.acs.org/doi/suppl/10.1021/acs.jproteome.8b00760/suppl_file/pr8b00760_si_001.xlsx), and the R code used to analyze it is available as [Supporting Information file S2](http://pubs.acs.org/doi/suppl/10.1021/acs.jproteome.8b00760/suppl_file/pr8b00760_si_002.pdf). The data set contains 16 samples, eight belonging to the cigarette smoke exposure group and eight controls, with 5244 peptides corresponding to 3646 unique proteins.

Data processing begins with replacing values of 0 with NA and log~2~ transforming the data. We then apply the molecule filter to remove any peptides observed in fewer than two samples, which removes 679 peptides and results in 4565 peptides mapping to 3150 proteins. A proteomics filter to remove peptides mapping to more than one protein results in 1738 peptides mapping to 508 proteins. Finally, the IMD-ANOVA filter is applied to remove any peptides for which we will be unable to perform either the quantitative or qualitative statistical comparisons between the smoking and control samples. After this filtering, we are left with 1513 peptides mapping to 436 proteins. EDA functionality is demonstrated by boxplots for each sample ([Figure [1](#fig1){ref-type="fig"}](#fig1){ref-type="fig"}A), PPCA plots of the peptide data ([Figure [1](#fig1){ref-type="fig"}](#fig1){ref-type="fig"}B), a bar graph showing the number of missing values per sample ([Figure [1](#fig1){ref-type="fig"}](#fig1){ref-type="fig"}C), and a Pearson correlation heatmap ([Figure [1](#fig1){ref-type="fig"}](#fig1){ref-type="fig"}D).

![(A) Boxplots for each log~2~ sample prior to QC. (B) The PPCA plot of the log~2~ peptide data without imputation of missing values shows minimal clustering of the treatment groups. (C) A bar graph of the number of missing values per sample does not reveal anything systematically different between the two groups or the individual samples. (D) The Pearson correlation heatmap among the log~2~-transformed samples shows some variation in correlation across the samples but nothing to indicate a potential outlying sample. (E) The rMd plot does not identify any potential sample outliers. (F) The values for each of the metrics included in the rMd calculation are indicated on boxplots for sample U54_SMOKEmp_119, which is the control sample having the highest log~2~ rMd score.](pr8b00760_0001){#fig1}

Potential sample outliers are identified using a combination of the EDA results and the rMd filter based on correlation, the proportion of missing values, MAD, and skewness. To focus on extreme outliers, a p-value threshold of 0.0001 is used, but this can be easily modified to fit the needs of the analysis. For this data set, no potential outliers are identified as having a log~2~ rMd score exceeding the log~2~ rMd threshold associated with a p-value of 0.001 ([Figure [1](#fig1){ref-type="fig"}](#fig1){ref-type="fig"}E). From [Figure [1](#fig1){ref-type="fig"}](#fig1){ref-type="fig"}F, we can see where the metrics of correlation, proportion of missing data, MAD, and skewness for the sample with the highest rMd score fall relative to those of the other samples. These bar plots are particularly helpful in determining which samples, if any, to remove when there are samples that are identified as potential outliers. In this analysis, no samples were removed.

SPANS^[@ref29]^ is used to select a normalization approach, where a heatmap of the SPANS scores for each combination of subset and normalization method ([Figure [2](#fig2){ref-type="fig"}](#fig2){ref-type="fig"}A) indicates the more recommended approaches in lighter colors (yellows). For this data set, the SPANS algorithm identifies the MAD based on the top 5% of order statistics (LOS 0.05) as the ideal normalization approach, which is based on 121 peptides. The second choice for the normalization approach is the MAD based on the top 20% of order statistics (LOS 0.2), which is based on 508 peptides. Because the second choice is based on a larger number of peptides and has a SPANS score only 0.0035 below the top choice, we proceed using the second choice ([Figure [2](#fig2){ref-type="fig"}](#fig2){ref-type="fig"}B).

![(A) Heatmap of the SPANS scores for each combination of data subset and normalization method that shows the use of the MAD of the LOS 0.05 peptides to be the top choice for the normalization approach, followed by the MAD of the LOS 0.2 peptides. (B) Boxplots for each sample that show the distributions of normalized log~2~ peptide abundance, where normalization was performed using the MAD of the LOS 0.2 peptides.](pr8b00760_0002){#fig2}

Protein quantification is performed using Rrollup,^[@ref30]^ which first scales all peptides that map to a given protein by a reference peptide (the peptide, out of all peptides mapping to the given protein, with the most observations) and then takes the median of the scaled peptides to obtain the relative protein abundance. This results in 436 proteins. Statistical analysis at the protein level is performed using both quantitative and qualitative tests^[@ref25]^ (IMD-ANOVA) on a protein by protein basis to compare the samples from the smoking group to the samples from the control group. A Holm p-value adjustment is used for the *p* values from both tests.

Results and Discussion {#sec4}
======================

Of the 436 proteins tested, 29 showed significant differences between the smoking and control groups (based on Holm adjusted p-values of \<0.05). Both the t-test and the g-test identified similar numbers of significant proteins that had a lower level of expression in the smoking group than in the control group. However, more proteins with a higher level of expression in the smoking group compared to the control group were identified as statistically significant by the g-test than by the t-test. There were 19 proteins that were found to be significant by the g-test and for which the t-test was not able to be run due to either the smoking or the control group having too few observed values. A graphical representation of the statistical results ([Figure [3](#fig3){ref-type="fig"}](#fig3){ref-type="fig"}) was generated using the plot() command on the statRes object and includes a bar plot for the number of significant proteins, a volcano plot for the results of the t-test, and a plot showing the number of observations per group for the g-test results.

![Graphical summary of the statistical results that includes (A) a bar graph of the number of significant proteins, both in total and broken out by statistical test, and (B) a volcano plot for the t-test (ANOVA) results (top) and a plot of the number of observations per group for the g-test results (bottom).](pr8b00760_0003){#fig3}

Conclusions {#sec5}
===========

The *pmartR* package is a collection of R functions that enable QC, EDA, and statistical processing of mass spectrometry data, without the necessity of imputing missing values. *pmartR* takes two to three data.frames, converts these to an S3 data object, and offers data cleaning, processing, summarizing, and statistical analysis capabilities. The *pmartR* package functions include automated tracking of the characteristics of the data \[e.g., data scale (log~2~, log~10~, natural log, and abundance), whether and how the data were normalized, what biomolecules or samples were filtered, group membership for each sample, etc.\], which streamlines analysis and reporting for the user. We provide sample data sets and R code as [Supporting Information](#notes1){ref-type="notes"} as well as additional example data sets in the *pmartRdata* package available on github that can be used for demonstration purposes. Therein, we demonstrate *pmartR*'s capabilities on a proteomics data set and present the results.

The Supporting Information is available free of charge on the [ACS Publications website](http://pubs.acs.org) at DOI: [10.1021/acs.jproteome.8b00760](http://pubs.acs.org/doi/abs/10.1021/acs.jproteome.8b00760).Supporting Information file 1 ([XLSX](http://pubs.acs.org/doi/suppl/10.1021/acs.jproteome.8b00760/suppl_file/pr8b00760_si_001.xlsx))Supporting Information file 2 ([PDF](http://pubs.acs.org/doi/suppl/10.1021/acs.jproteome.8b00760/suppl_file/pr8b00760_si_002.pdf))
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:   mass spectrometry
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:   PCA probabilistic principal components

rMd

:   robust Mahalanobis distance

SPANS

:   statistical procedure for the analysis of peptide abundance normalization strategies
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